Animuscure Inc.
- Biotech or pharma, therapeutic R&D
AniMusCure Inc. is a specialized R&D company focused on developing groundbreaking therapies for muscle disorders, including sarcopenia, to enhance quality of life by addressing aging and frailty. Our lead programs comprise first-in-class sarcopenia therapeutics and GLP-1-based combination treatments, both designed to boost muscle mass, strength, and function.
We also possess a Human iPSC-Derived Neuromuscular Organoid Platform and a Human iPSC-Derived Cardiac Organoid Platform. These platforms, derived from Human induced pluripotent stem cells (iPSCs), are pivotal in advancing our research and development of innovative treatments for muscle-related conditions.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}